The following article was featured in:
Source:
WCCB Charlotte's CWWCCB Charlotte's CW
06/11/2025.
WASHINGTON DC The Food and Drug Administration has approved a new monoclonal antibody to protect infants from RSV.
The infection is the top cause of infant hospitalization in the U.S. and can be...
Continue on to full article...
